CD8(+) T cells armed with retrovirally transduced IFN-gamma

Area of Science:

• Immunology
• Molecular Biology
• Cancer Research

Background:

• Interferon-gamma (IFN-gamma) is crucial for T cell responses against pathogens and tumors.
• Therapeutic strategies often aim to enhance T cell effector functions, including IFN-gamma production.

Purpose of the Study:

• To investigate the feasibility of equipping CD8 T cells with enhanced interferon-gamma (IFN-gamma) production capacity.
• To assess the safety and efficacy of retrovirally-mediated IFN-gamma gene transfer into T cells.

Main Methods:

• Retroviral transduction of IFN-gamma cDNA into CD8(+) T cells from both wild-type and IFN-gamma knockout mice.
• Analysis of IFN-gamma mRNA transcription, protein translation, and secretion upon T cell activation.
• Assessment of T cell proliferation, cytolytic activity, and tumor suppressive capacity in vivo.

Main Results:

• CD8 T cells successfully acquired the capacity to secrete IFN-gamma following retroviral transduction.
• IFN-gamma expression was tightly regulated, occurring only upon T cell activation, preventing constitutive secretion.
• Transduced T cells showed no impairment in proliferation or cytolytic function.
• Adoptive transfer of IFN-gamma-equipped T cells into IFN-gamma(-/-) mice resulted in enhanced tumor suppression.

Conclusions:

• T cells can be effectively engineered to produce IFN-gamma without adverse effects on their fundamental functions.
• This method provides a safe approach to enhance T cell-mediated tumor suppression by augmenting IFN-gamma secretion.
• Retroviral gene transfer offers a viable tool for arming T cells with therapeutic cytokines like IFN-gamma for cancer immunotherapy.